Severance Hospital, Yonsei University Health System ( Site 0903)

Seoul 03722

1 studies enrolling now · 2 studies all time

What they study most

Gastrointestinal Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02) — Recruiting now
• A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) — Completed